*BMI intends to seek FDA Clearance for its first mobile device in 2023 and once secured to begin by focusing on the Kidney Transplant market.
*Computer-generated images: depict envisaged commercial OrganBank™ Transport and OrganBank™
Temperature control ramping available from 4 to 37 degrees
The ability to recover discarded organs
Extend the time from 6 hours to more than 24 hours that the organs are viable for transplant
Proven and patented technology and ‘methods & apparatus’ regularly used to perfuse an array of different organs and tissue types
Customizable waveform on a portal and arterial circuit
Our edge to cloud data will give valuable information to the surgeons and patient
The OrganBank is a self-contained organ preservation system, designed to support multiple organs at a time. The OrganBank provides controlled pulsatile perfusion using an oxygenated accelluar perfusion solution in a temperature controlled setting. The system is capable of monitoring each of the hosted organs, displaying important perfusion parameters, including: perfusate flow, temperature, pressure, and vascular resistance. It features easily accessible aseptic organ cassettes, which facilitate quick connections and release, from/to the OrganBank portable organ transport system. Optionally, the OrganBank provides dialysis of the perfusion solution for extended periods of organ maintenance.
One system that is adaptable for multiple different organs: Kidney, Liver, Lungs, Intestine, Brains, and Vascularized Composite Allografts (VCA).
Customizable waveform on a portal and arterial circuit.
Temperature control ramping available from 4 to 37 degrees.
Scissor lift system for height adjustments and for better storage when transporting.
Storage for One-time use Organ Cradles.
This technology has been built into a transport organ carrier that will preserve the organ during transportation. Today organ transportation is restricted to only 500 miles…. Our technology will deliver coast-to-coast capability – and even International reach.
While in transit, we will share real-time tracking and condition data to the surgeons so they can make a conscious decision to proceed with transplant, even before seeing the organ.
For the first time we are providing transparency for the patients that will help remove patients anxiety, and create peace of mind prior to these life changing operations.
*BMI intends to seek FDA Clearance for its first mobile device in 2023 and once secured to begin by focusing on the Kidney Transplant market.
*Computer-generated images: depict envisaged commercial OrganBank™ Transport and OrganBank™
© 2023 BioMedInnovations. All rights reserved by BMI LLC
